ICON plc/$ICLR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
Ticker
$ICLR
Sector
Primary listing
Employees
40,350
Headquarters
Dublin, Ireland
Website
ICON plc Metrics
BasicAdvanced
$13bn
74.77
$2.22
1.22
-
Price and volume
Market cap
$13bn
Beta
1.22
52-week high
$203.91
52-week low
$66.57
Average daily volume
861k
Financial strength
Current ratio
1.138
Quick ratio
1.093
Long term debt to equity
32.021
Total debt to equity
38.095
Interest coverage (TTM)
4.69%
Profitability
EBITDA (TTM)
1,305.105
Gross margin (TTM)
25.32%
Net profit margin (TTM)
2.10%
Operating margin (TTM)
11.22%
Effective tax rate (TTM)
12.86%
Revenue per employee (TTM)
$200,000
Management effectiveness
Return on assets (TTM)
3.51%
Return on equity (TTM)
1.84%
Valuation
Price to earnings (TTM)
74.768
Price to revenue (TTM)
1.552
Price to book
1.37
Price to tangible book (TTM)
-4.84
Price to free cash flow (TTM)
16.913
Free cash flow yield (TTM)
5.91%
Free cash flow per share (TTM)
9.801
Growth
Revenue change (TTM)
1.92%
Earnings per share change (TTM)
-74.35%
3-year revenue growth (CAGR)
1.89%
10-year revenue growth (CAGR)
17.95%
3-year earnings per share growth (CAGR)
-28.95%
10-year earnings per share growth (CAGR)
-6.16%
What the Analysts think about ICON plc
Analyst ratings (Buy, Hold, Sell) for ICON plc stock.
ICON plc Financial Performance
Revenues and expenses
ICON plc Earnings Performance
Company profitability
ICON plc News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.